RxDoctor Payments Data

Jason Baron, MD

Psychiatry · Houston, TXNPI 1104865260

Payments from drug & device makers

$996in general payments, 2019–2025

Across 54 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$553
  • Teva Pharmaceuticals USA, Inc.$134
  • Indivior Inc.$118
  • Otsuka America Pharmaceutical, Inc.$72
  • E.r. Squibb & Sons, L.L.C.$25
  • Lundbeck LLC$24
  • plus $71 from 4 others

What the payments were for

  • Food & beverage$996100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$996 in reported general payments places this provider in the 65th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$245,413
Medicare patients
131
Services billed
6,876

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate45$137,587
IngrezzaValbenazine Tosylate12$96,399
XareltoRivaroxaban16$8,506
Lurasidone Hcl27$6,158
Varenicline Tartrate16$2,831
Atomoxetine Hcl25$1,953
Aripiprazole45$1,798
Trazodone Hcl174$1,780
Desvenlafaxine Succinate ErDesvenlafaxine Succinate63$1,693
Fluphenazine Hcl17$1,618
Gabapentin169$1,563
Doxepin Hcl68$1,501
Oxcarbazepine33$1,167
Hydroxyzine Pamoate86$1,110
Benztropine Mesylate117$984

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Xarelto$553$146,09361 claims
Neurocrine Biosciences, Inc.Ingrezza$13$96,39912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →